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Macrophages are pivotal in mounting liver inflammatory and tissue repair responses upon
hepatic injury, showing remarkable functional plasticity. The molecular mechanisms
determining macrophage transition from inflammatory to restorative phenotypes in the
damaged liver remain unclear. Using mouse models of acute (APAP) and chronic (CCl4)
drug-induced hepatotoxic injury we show that the immune receptor Trem-2 controls
phenotypic shifts of liver macrophages and impacts endothelial cell differentiation during
tissue recovery. Trem-2 gene ablation led to a delayed re-population of Kupffer cells
correlating with deterred resolution of hepatic damage following acute and chronic injury.
During tissue recovery, we found that macrophages transitioning to Kupffer cells
expressed high levels of Trem-2. Acquisition of the transition phenotype was
associated with a unique transcriptomic profile denoting strong responsiveness to
oxidative stress and downmodulation of the pro-inflammatory phenotype, which was
not observed in absence of Trem-2. During tissue recovery, lack of Trem-2 favored
accumulation of a liver-damage associated endothelial cell population (LDECs), whose
transcriptional program was compatible with endothelial de-differentiation. Accordingly,
LDECs precursor potential is supported by the downregulation of surface endothelial cell
markers and by striking in vitromorphological changes towards typical endothelial cells. In
conclusion, we found that the dynamics of liver macrophages in response to liver injury are
critically controlled by Trem-2 and this regulation is interlinked with the de-differentiation of
endothelial cells and heightened liver pathology. We propose that Trem-2 promotes the
transition from pro-inflammatory to tissue repair phase by driving the acquisition of
restorative properties in phagocytic macrophages.
Keywords: triggering receptor expressed on myeloid cells 2, macrophages, tissue repair and organ regeneration,
inflammation, carbon tetrachloride 4, acetaminophen (paracetamol), endothelial cellsorg February 2021 | Volume 11 | Article 6160441
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Hepatotoxic insults elicit a multilayered response involving
damaged tissue clearance, scar formation and tissue
regeneration. Macrophages play decisive roles in inflammatory
and tissue repair responses during acute and chronic liver injury
(1–3) as well as in liver damage due to metabolic disorders such
as NAFLD (4, 5), type 2 diabetes and obesity (6).
In damaged hepatic tissue, macrophages with different
surface phenotypes and activation status show sharp
population dynamics (1, 3) suggesting that distinct
macrophage populations perform specific activities that
determine the course of response to tissue damage.
Macrophage involvement in response to severe damage is often
initiated by influx of hematopoietic-derived monocytes that
home the liver as Ly6c+ cells and dominate the liver
macrophage populations at this stage (2, 3, 7). These Ly6c+
cells present a high-inflammatory phenotype including the
expression of TNF-a, IL-1b and TGF-b signals that amplify
tissue pathology and also, in chronic tissue injury promote
transdifferentiation of stellate cells into collagen-producing
myofibroblasts, a hallmark of liver fibrosis (1).
Conversely, tissue repair and fibrosis resolution are associated
with the emergence of macrophages that phenotypically
resemble liver resident macrophage cells (1, 3). These pro-
resolution macrophages show phagocytic ability and express
high levels of metalloproteinases and anti-inflammatory
mediators (e.g. MMP12 and Arg1) that trigger myofibroblasts
apoptosis and actively participate in extracellular matrix
degradation (1). Still, however, it is unclear what regulates the
dynamics of different liver macrophage populations during
response to damage. Macrophages show remarkable
phenotypic and functional plasticity and are equipped to
undergo functional transitions, depending on contextual cues
(8, 9). Interestingly, it has been shown that pro-inflammatory
macrophages can acquire anti-inflammatory and pro-repair
phenotypes (1, 3, 10) but the triggers for this phenotype switch
in liver macrophages remain largely unknown (1, 9).
Triggering receptor expressed on myeloid cells-2 (Trem-2) is
a transmembrane immune receptor typically expressed in the
monocyte/macrophage lineage (11). Upon ligand binding Trem-
2 signals through the adaptor DAP12, thereby modulating
activation of macrophage effector functions (12). Trem-2 has
been intensively studied in the context of neurodegenerative
diseases, revealing its concurrent role in the engulfment of ab-
amyloid plaques during Alzheimer’s disease (13) and in
phagocytosis of apoptotic neurons (14). In addition, Trem-2
signaling was shown to limit tissue destruction and to facilitate
both repair and cellular debris clearance in a model of
Experimental Autoimmune Encephalomyelitis (EAE) (15).
Trem-2 ligands leading to macrophage activation in situ have
not been identified, however various studies have reported on a
binding to phospholipids such as phosphatidylserine (14, 16) and
a range of acidic and zwitterionic lipids (13), which may
accumulate upon cell damage.
Furthermore, Trem-2 has been shown to modulate microglia
survival through Wnt/b-catenin signaling (17, 18) and also toFrontiers in Immunology | www.frontiersin.org 2promote inhibitory signals that restrain pro-inflammatory
macrophage activation (19, 20). Recent studies have also
illustrated that Trem-2 is required for the activation of a
specific transcriptional gene program which controls
phagocytosis and lipid metabolism of microglial cells in
Alzheimer’s disease (21) and of lipid associated macrophages
(LAM) in metabolic disorders (22).
The impacts of Trem-2 in liver macrophages have been less
explored. Previous findings from our laboratory uncovered that
Trem-2 is expressed on Kupffer cells (KCs) determining their
activation profile upon contact with malaria parasite (23).
Recently published work (24) revealed that Trem-2 is involved
in liver damage and proposed that Trem-2 expression in non-
parenchymal cells acts as a brake of the inflammatory response
during hepatotoxic injury. Although this established a link
between Trem-2 and liver inflammation, specific effects on
macrophages, the critical players in these processes,
remain unsettled.
Here we uncovered that upon experimental induction of
hepatic injury Trem-2 controls dynamics of liver macrophage
populations favoring replenishment of Kupffer cells and
consequently promoting tissue damage resolution and
regeneration of the hepatic tissue, including the endothelial
cell lineage.MATERIALS AND METHODS
Mice and Experimental Models
All procedures involving laboratory mice were in accordance
with national (Portaria 1005/92) and European regulations
(European Directive 86/609/CEE) on animal experimentation
and were approved by the Instituto Gulbenkian de Ciência
Ethics Committee and the Direcção-Geral de Veterinária
(the Official National Entity for regulation of laboratory
animals usage). Trem2-deficient mice in a C57BL/6
background (19) were kindly provided by Marco Colonna,
Washington University School of Medicine, St. Louis,
MO. C57BL/6 mice, Trem-2 KO and B6.Actin-GFP mice
were bred and housed under a 12-hr light/dark cycle in
specific pathogen free housing facilities at the Instituto
Gulbenkian de Ciência.
To induce acute liver injury, C57BL/6 and Trem-2 KO male
mice with 10 weeks of age were fasted for 15 hours prior to intra-
peritoneal injection with 300mg/Kg of acetaminophen (N-acetyl-
p-aminophenol (APAP)) (3) (Sigma, St. Louis, MO, USA) in PBS
or PBS only. Liver and blood were collected at day 1 (D1) and 3
(D3) after injection.
In the model of chronic liver fibrosis and fibrosis regression,
C57BL/6 and Trem-2 KO males with 7–8 weeks of age received
PBS or 20%v/v carbon tetrachloride (CCl4, Sigma, St. Louis, MO,
USA) in olive oil, administered at 0,4mL/Kg, twice a week during
4 weeks by intra-peritoneal injections (1). Liver and blood were
collected at day 1 (fibrosis) or day 3 post-injection
(fibrosis regression).
For the in vivo phagocytosis experiments, mice were given a
retro-orbital injection of 50x106 beads/200uL fluorescent beadsFebruary 2021 | Volume 11 | Article 616044
Coelho et al. Trem-2 in Liver Repair Responses(Fluoresbrite YG microspheres 2mm, Polysciences) 3 days after
APAP treatment and 1 h prior liver collection.
Non-Parenchymal Cells Isolation, Flow
Cytometry and Cell Sorting
Non-parenchymal cells (NPCs) were isolated from liver lobes by
perfusion with Collagenase H (Sigma, St. Louis, MO, USA)
followed by density centrifugation as previously described (25,
26). Non-parenchymal cells (NPCs) were immuno-labeled with
fluorochrome-conjugated antibodies (eBiosciences and
BioLegend) followed by flow cytometry analysis (LSR Fortessa
X20™, BD) or cell sorting (FACSAria, BD). Antibodies are listed
in Supplementary Methods.
Histology
Histological analyses were performed in the Histopathology
Unit of Instituto Gulbenkian de Ciência. Livers were fixed in
10% formalin and embedded in paraffin. Non-consecutive
3µm sections were stained with hematoxylin-eosin or
Mason’s Trichrome and examined under light microscope
(Leica DM LB2, Leica Microsystems, Wetzlar, Germany).
Necrosis and fibrosis were blindly assessed by a trained
pathologist. Necrosis scoring: 0, no necrosis; 1, single cell
centrilobular necrosis to centrilobular necrosis without central
to central bridging necrosis; 2, centrilobular necrosis with
central to central bridging; 3, centrilobular necrosis with
central to central bridging and focal coalescent foci of
necrosis; 4, centrilobular necrosis with central to central
bridging with large coalescent foci of necrosis. Fibrosis was
assessed using Ishak system adaptation: 0, no fibrosis; 1,
fibrous expansion in some centrilobular areas with or
without fibrous septa; 2, fibrous expansion of most
centrilobular areas with or without fibrous septa; 3, fibrous
expansion of most centrilobular areas with occasional central
to central bridging; 4, fibrous expansion in most centrilobular
areas with marked central to central bridging; 5, marked
bridging (C-C) with occasional nodules; 6: cirrhosis. Images
were acquired on a Leica DM LB2 and a commercial Leica
High Content Screening microscope.
For immunofluorescence, PFA fixed cells were stained
overnight at 4°C with rat anti-mouse F4/80 diluted 1:50 and
rabbit anti-mouse caspase-3, diluted 1:500. On the following
day sections were washed and incubated with respective
secondary antibodies for 1h at room temperature. Images
were acquired using a 5x5 tile-scan protocol on a Nikon Ti
microscope using a 20x 0.75 NA objective, coupled with an
Andor Zyla 4.2 sCMOS camera (Andor, Oxford Instruments)
and controlled through Nikon NIS Elements (Nikon). DAPI,
F4/80 and caspase-3 were acquired using a DAPI, Cy5 and
TRITC filtersets, respectively. Detailed methods for analysis
can be found in Supplementary Methods.
AST/ALT
Serum levels of Aspartate aminotransferase (AST) and Alanine
aminotransferase (ALT) were determined by a colorimetric
enzymatic assay using the GOT-GPT kit (Spinreact S.A.,
Spain) according to manufactures’ instructions.Frontiers in Immunology | www.frontiersin.org 3RNA Isolation and Gene
Expression Analysis
NPCs were collected in lysis buffer (RNeasy MiniKit- Qiagen) and
total RNA was obtained using RNeasy MiniKit (Qiagen) and
converted to cDNA (Transcriptor First Strand cDNA Synthesis
Kit, Roche). Cells-to-ct kit (Applied Biosystems) was used to
amplify cDNA from sorted cells. Taqman gene expression assays
(TNFa Mm00443258_m1, trem2 Mm00451744_m1, Applied
Biosystems) and endogenous control GAPDH were used in
multiplex Real-Time PCR reactions (ABI QuantStudio-384,
ThermoFischer). Results represent relative quantification
calculated using the 2-DDCT method and normalized to GAPDH.RNA SEQUENCING
Cell Sorting and RNA Sequencing Analysis
Macrophage populations and CD45neg SSChi population were
sorted directly into Qiagen RLT lysis buffer. Each sample
represents a pooling of 4 mice. Biological replicates were used
for each population except for KCs control. Sequencing was
performed at the Genomics Unit, Instituto Gulbenkian de
Ciência (IGC, Portugal) following a previously established
protocol (27). Briefly, RNA was separated from gDNA using a
modified oligo-dT bead-based strategy and DNA libraries were
prepared using Pico Nextera protocol. Sequencing was
performed using NextSeq500- High Output Kit v2 (75 cycles),
single-ended, 20 million reads per sample. Detailed methods for
analysis can be found in Supplementary Methods.
Statistics
To analyze differences across genotypes in treated animals we
calculated that a sample size of 5 animals per group would be
necessary tohave80%power todetect ameanphenotypicdifference
higher than 9% at 0.05 significance level. Initial experiments
detecting statistical differences, were independently replicated,
namely at day 3 post treatments, and their cumulative results are
shown. We avoid replicating experiments with initial negative
results to prevent unnecessary use of animals. Chi-square test was
used to analyze proportions of categorical variables while one-way
ANOVA was used to compare means within genotypes and two-
way ANOVA to compare means between genotypes. Pearson’s
correlation was used to test for correlation between two variables
and Man-Whitney test was use to compare mean intensity
fluorescence ranks. Statistics were calculated with GraphPad
Prism version 6.
In Supplementary Methods section we provide additional
details on Materials and Methods.RESULTS
Trem-2 Ablation Deters Tissue Repair
Upon Acute Liver Injury
To study the role of Trem-2 in responses to acute liver injury we
used a well-established experimental model (3). Mice received aFebruary 2021 | Volume 11 | Article 616044
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day (D1) or 3 days (D3), corresponding to the times of hepatic
damage and tissue repair responses, respectively (Figure 1A).
During acute injury (D1) wild-type and Trem-2 KO mice
showed regions of massive necrosis in the liver (Figures 1B,
C). At D3 wild-type had almost completely cleared necrosis
while Trem-2 KO mice retained marked liver pathology with
wide coalescent necrotic areas (Figures 1B, C). Serum levels of
hepatic enzymes AST and ALT at day 1 and day 3 and
histological analysis at day 1 indicated that the intensity of
APAP hepatotoxicity and the extent of tissue damage was not
affected by Trem-2 expression (Figures 1D, E). Nevertheless, the
persistence of larger necrotic areas at day 3 indicate that althoughFrontiers in Immunology | www.frontiersin.org 4wild-type and Trem-2 KO mice were similarly affected by acute
liver injury, resolution of liver damage in Trem-2 KO mice was
impaired. These data show that although wild-type and Trem-2
KO mice were similarly affected by acute liver injury, resolution
of liver damage in Trem-2 KO mice was impaired.
Trem-2 Impacts on Non-Parenchymal
Cells Dynamics During Recovery From
Acute Liver Damage
Given the role of Trem-2 in macrophage functional activation
(19) we isolated non-parenchymal cells (NPCs) from APAP-
treated mice at the time points of liver injury (D1) and tissue





FIGURE 1 | Trem-2 KO mice show impaired recovery from liver damage induced by APAP. Acute liver damage induced by single intra-peritoneal administration of
acetaminophen (APAP) was assessed 1 day (APAP-D1) or 3 days (APAP-D3) post-injection of wild-type and Trem-2 KO mice (A). Hepatocyte necrosis was
evaluated using hematoxylin-eosin staining (B) and scored from 0 to 4 according to location and extension of the necrotic lesions (C). Liver damage was assessed
by quantification of hepatic enzymes AST (D) and ALT (E) in the serum. Mean values and standard deviations are represented. Statistics: Chi-square test in necrosis
scoring (C); One-way ANOVA in (D); (n=6-11 mice/group). ****, p<0.0001.February 2021 | Volume 11 | Article 616044
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macrophages (RHM) (CD45+ Ly6c+ F4/80int CD11bhigh)
known to promote tissue inflammation (7, 28) were
predominant at D1 but declined during the tissue repair phase
(D3). RHM were found in similar proportions in wild-type and
Trem-2 KOmice, suggesting that macrophage recruitment to the
liver was not affected in absence of Trem-2 (Figures 2A, B). As
expected, Kupffer cells (KCs) (CD45+ Ly6c- F4/80hi CD11bint)Frontiers in Immunology | www.frontiersin.org 5were highly represented in untreated mice and were severely
reduced during injury (D1) in wild-type and Trem-2 KO mice
(Figures 2A, B). However, we noted that in the tissue repair
phase (D3) the recovery of KCs was slower in Trem-2 KO mice
(Figures 2A, B and Supplementary Figure 1). We have recently
shown that levels of CD26 enzymatic activity, from unidentified
cellular sources, is a serum biomarker that mirrors severe
reductions in KCs population (26). Quantification of CD26A
B
D EC
FIGURE 2 | Impaired KC replenishment upon acute liver injury in Trem-2 KO mice and accumulation of non-hematopoietic CD45neg SSChi cells. Flow cytometry
analysis of liver non-parenchymal cells (NPCs) from wild-type and Trem-2 KO mice (control versus D1 versus D3) revealed distinct macrophage populations and a
non-hematopoietic cell population (CD45neg SSChi). Among macrophages we identified Ly6c+ recruited hepatic macrophages (RHM, CD45+ Ly6c+ F4/80low
CD11b+) and Ly6c- macrophages, namely, Kupffer cells (KC, CD45+ Ly6c- F4/80high CD11bint); transition macrophages (Trans, CD45+ Ly6c- F4/80int
CD11bhigh); and recruited-like macrophages (RLM, CD45+ Ly6c- F4/80low CD11b+) (A). Cell frequencies of macrophage populations (B) and non-hematopoietic
CD45neg SSChi population (C) in control, APAP-D1 and APAP-D3 wild-type and Trem-2 KO mice. Inverse correlation of KC frequency with CD45neg SSChi
population at APAP-D3 (D). Correlation of CD45neg SSChi cells frequency with necrosis scoring at APAP-D3 (E). Symbols represent values from individual mice
(n=6-11 mice/group). Group mean values are presented. Statistics: Two-way ANOVA in (B, C) Pearson’s correlation test in (D, E) *, p<0.05 **, p<0.01 ***, p<0.001
****, p<0.0001.February 2021 | Volume 11 | Article 616044
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slightly higher levels of CD26 activity (Supplementary Figure
2A) corroborating the delayed KCs replenishment in Trem-2
KO mice.
Interestingly, our analysis revealed two related liver Ly6c-
macrophage populations with distinctive surface phenotypes: a
CD45+ Ly6c- F4/80low CD11b+ population enriched at D1 and
resembling the typical recruited Ly6c+ counterpart, herein
named as recruited-like macrophages (RLM) (Figure 2A) and
a CD45+ Ly6c- F4/80+ CD11bhi population showing a surface
phenotype close to KCs and named as transition macrophages
that was strikingly enriched during tissue repair (D3) (Figures
2A, B). In contrast to KCs these populations accumulated in
Trem-2 KO mice at D3 (Figure 2B) indicating that in absence of
Trem-2 dynamics of macrophage hepatic repopulation was
altered during tissue repair response.
Using GFP-labeled monocyte transfers we show that after
acute liver injury recruited bone-marrow monocytes give rise to
RLM, transition macrophages and KCs (Supplementary Figure
3). Together, these results suggest that in response to acute liver
damage Trem-2 is a determinant of macrophage population
dynamics promoting the replenishment of the KCs niche from
recruited monocytes.
In addition, flow cytometry analysis uncovered a previously
unnoticed non-hematopoietic CD45neg SSChi population that
emerges at D3 and accumulates in Trem-2 KO mice (Figures
2A, C) paralleling the accumulation of transition macrophages.
Strikingly, we noted that accumulation of non-hematopoietic
CD45neg SSChi cells inversely correlate with the KCs proportion
in the livers of wild-type and Trem-2 KO mice (Figure 2D) and
directly correlated with the persistence of liver necrosis (Figure
2E). These findings suggest that in absence of Trem-2,
imbalanced replenishment of liver macrophages associated
with accumulation of transition macrophages results in
overrepresentation of a non-parenchymal cell population,
which correlates with impaired resolution of liver necrosis.
Trem-2 Ablation Delays Tissue Repair and
Alters Non-Parenchymal Cell Dynamics in
Chronic Liver Damage
To extend our observations to chronic liver damage wild-type
and Trem-2 KO mice were exposed to carbon tetrachloride
(CCl4) treatment for 4 weeks and analyzed on day 1 (D1) and
day 3 (D3) after treatment corresponding to established liver
fibrosis and fibrosis regression time points, respectively (Figure
3A). At D1 Trem-2 KO mice showed a stronger fibrotic
phenotype, with increased hepatocyte necrosis and fiber
deposition (Figures 3B–D). Strikingly, fibrosis resolution
response was compromised in Trem-2 KO mice by D3 as
indicated by persistence of necrosis and collagen deposition
that contrasted with nearly complete necrosis clearance and
significant fibrosis regression in wild-type mice (Figures 3B–D).
Accordingly, analysis of macrophage dynamics revealed
that recruitment of macrophages at D1 was not affected in
Trem-2 KO mice but at D3 KCs replenishment was impaired
and non-hematopoietic CD45neg SSChi cells were notoriouslyFrontiers in Immunology | www.frontiersin.org 6overrepresented (Figures 3E, F). Additionally, serum levels of
CD26 activity tend to be higher at D3 in Trem-2 KO mice
(Supplementary Figure 2B), strengthening the notion that KCs
recovery was delayed in these mice. Similar to the acute model,
CD45neg SSChi cells accumulation at D3 was inversely correlated
with KC proportions (Figure 3G) and associated with the
persistence of liver necrosis (Figure 3H). Furthermore, genetic
expression of TNF-a in non-parenchymal cells (NPCs)
correlated with the proportions of CD45neg SSChi cell
population (Supplementary Figure 4). These data reinforce
that ablation of Trem-2 impacts the dynamics of macrophage
populations favoring a pro-inflammatory milieu and
accumulation of CD45neg SSChi cells that are in turn associated
with delayed resolution of tissue damage.
Trem-2 Is Upregulated in Transition
Macrophages Promoting Acquisition of
Resident-Like Phenotype
Trem-2 RNA expression was quantified in sort-purified
macrophage populations and non-hematopoietic CD45neg
SSChi cells from wild-type mice 3 days after APAP treatment
(D3) (Supplementary Figure 5A). Remarkably, Trem-2
expression was upregulated in transition macrophages and
almost undetectable in the other macrophage populations
(Figure 4A). This strongly suggests that expression of Trem-2
in the transition macrophage population promotes adequate
dynamics of KCs replenishment. Furthermore, Trem-2 was not
expressed in CD45neg SSChi cells (Figure 4A) suggesting that
their accumulation in Trem-2 KO mice may result from
abnormal macrophage responses.
Analysis of F4/80 surface expression revealed that Ly6c-
macrophages from Trem-2 KO mice present decreased surface
expression of F4/80 molecule upon acute (Figure 4B) and
chronic (Figure 4C) injury. An in vivo phagocytosis functional
assay with fluorescent beads at D3 after APAP treatment show
that Trem-2 KO macrophages have decreased ability to
phagocytose compared to wild-type (Figure 4D). Furthermore,
we found that Trem-2 KO transition macrophages in culture
maintain a rounder shape as assessed by the total F4/80 area
(Figure 4E), while wild-type macrophages acquire a typical KC-
like morphology. This suggests that Trem-2 is involved in the
phenotype switch from transition to resident-like macrophage.
Quantification of caspase-3 expression in culture and ki67 ex
vivo staining in Trem-2 KO transition macrophages showed
increased apoptosis and decreased proliferation (Figures 4E, F).
These results indicate that ablation of Trem-2 impairs KCs
replenishment possibly by controlling cell survival and
therefore allowing the transition into KCs.
Trem-2 Increases Resilience to Oxidative
Stress and Swift Shutdown of Pro-
Inflammatory Program in Transition
Macrophages
To better discern the functional role of Trem-2 in macrophage
phenotypic shifts we performed transcriptomic analysis in sort-
purified macrophage populations of wild-type and Trem-2 KOFebruary 2021 | Volume 11 | Article 616044
Coelho et al. Trem-2 in Liver Repair Responsesmice (Supplementary Figure 4A) at D3 after APAP treatment.
Hierarchical algorithms and principal component analysis
(PCA) clustered the different macrophage populations and
clearly showed that the transcriptional profiles of RHM are in
the vicinity of RLM and that transitional macrophages are closer
to KCs (Figure 5A and Supplementary Figure 5A). This is in
agreement with accepted notions that recruited macrophages
(RHM) home the liver as inflammatory macrophages and looseFrontiers in Immunology | www.frontiersin.org 7Ly6c expression subsequently giving rise to transition
macrophages and KCs (1, 29).
On the other hand, wild-type and Trem-2 samples were
clustered within each macrophage population (Figure 5A),
suggesting that Trem-2 does not have a major impact in the
global macrophage transcriptional programs. Given that Trem-2
affects the dynamical switching of transitional macrophage





FIGURE 3 | Responses to chronic liver injury are impaired in Trem-2 KO mice. Chronic liver injury was induced by administration of CCl4 during 4 weeks, twice a
week. Mice were analyzed one or three days after the last injection, corresponding to fibrosis-D1 and fibrosis regression-D3 time points in wild-type mice (A). Liver
necrosis was evaluated using hematoxylin-eosin (H&E) staining (B) and scored from 0 to 4 according to location and extension of the necrotic lesions (C). Masson’s
trichrome (MT) staining was used to identify and quantify collagen fibers (blue) (B) using an adapted Ishak grading (D). Applying the flow cytometry criteria depicted
in Figure 2 we quantified cell frequencies of distinct macrophage populations: recruited hepatic macrophages (RHM); Kupffer cells (KC); transition macrophages
(Trans); recruited-like macrophages (RLM) (E) and of non-hematopoietic CD45neg SSChi population (F) in wild-type and Trem-2 KO mice for control, fibrosis-D1 and
fibrosis regression-D3 time points. Inverse correlation of KC frequency with CD45neg SSChi population at Fibrosis Regression-D3 (G). Correlation of CD45neg
SSChi cells frequency with necrosis scoring at fibrosis regression-D3 time point (H). Symbols represent values from individual mice. Group mean values are
presented. Statistics: For necrosis and Ishak grade scorings, groups were compared using Chi-square test (n=18-48 mice/group) (C). Two-way ANOVA in (E) and
(F) Pearson’s correlation test in (G, H) *, p<0.05 ***, p<0.001, ****, p<0.0001.February 2021 | Volume 11 | Article 616044
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macrophages. We found that the transcriptional shift was more
prominent in wild-type mice than in Trem-2 KO mice (Figures
5B, C). Interestingly, this shift encompassed the upregulation of
genes associated to oxidation-reduction processes and
downregulation of genes associated with inflammatory
responses (Figure 5D), a pattern that was not observed in
Trem-2 KO cells. We measured by qPCR the expression of two
of these upregulated genes (Hmox1 and Fth1) in sorted
transition macrophages confirming that activation of oxidativeFrontiers in Immunology | www.frontiersin.org 8stress response mechanisms are blunted in Trem-2 KO transition
macrophages (Supplementary Figure 6A). This analysis
suggests that the transition macrophage transcriptional
program was not fully acquired in Trem-2 KO cells.
Furthermore, comparison of transition macrophages and
replenished KCs again showed that the transcriptional
program switch is considerably less prominent in Trem-2 KO
mice (Figure 5E). Gene ontology analysis revealed that genes
specifically upregulated in transition macrophages from Trem-2





FIGURE 4 | Trem-2 is implicated in acquisition of liver transition macrophages phenotype. Trem-2 gene expression was evaluated by qPCR in sort-purified
macrophage populations and in non-hematopoietic cell population, CD45neg SSChi in wild-type mice and represented as fold change to transition macrophages
(A). F4/80 mean fluorescence intensity (MFI) among F4/80int/high non-parenchymal cells from wild-type and Trem-2 KO mice at APAP-D3 (B) and fibrosis
regression-D3 (C). Percent of F4/80int/high non-parenchymal cells containing fluorescent beads in wild-type and Trem-2 KO at APAP-D3 1 h after i.v. injection of
50x106 2mm Yellow-Green fluorescent microspheres (D). Immunofluorescence of sort-purified APAP-D3 transition macrophages from wild-type and Trem-2 KO
mice after 3 days of culture (Nuclei (blue), F4/80 (red), caspase-3 (green). Merged images are shown and quantification of F4/80 and caspase-3 stained area
normalized by nuclei is plotted (E). Representative flow cytometry plots showing Ki67 staining in APAP-D3 transition macrophages from wild-type and Trem-2 KO
mice (F). Statistics: One-way ANOVA and Tukey’s correction in (A) Mann Whitney test in (B, C) *, p<0.05.February 2021 | Volume 11 | Article 616044
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In addition, we analyzed the transcriptional switch between
recruited macrophage populations comparing RHM to RLM
and found a similar change extent in wild-type and Trem-2
KO mice (Supplementary Figure 6B). Moreover, gene ontology
analysis showed that irrespective of Trem-2 expression, RLMFrontiers in Immunology | www.frontiersin.org 9have a transcriptional profile of increased proliferative capacity
(Supplementary Figure 6C). Taken together these results show
that Trem-2 expression in transition macrophages is key to
shutdown the pro-inflammatory transcriptional program and
increase resilience to oxidative stress during acquisition of





FIGURE 5 | Transcriptomic profiling identifies a Trem-2 dependent program in transition macrophages. Principal component analysis (PCA) of transcriptomic data
representing clustering of different sort-purified macrophage populations (represented by colors) from wild-type (circles) and Trem-2 KO mice (triangles) (A). Volcano
plots representing differential expressed (DE) genes (q<0.05) between transition and recruited-like macrophages (RLM) in wild-type and Trem-2 KO mice. Red dots
represent upregulated genes (LogFC>0), while blue dots represent downregulated genes (LogFC<0) (B). Venn diagram representing DE-genes between transition
and RLM, which are common to wild-type and Trem-2 KO mice (middle), exclusively detected in wild-type (left) or in Trem-2 KO (right) (C). Gene Ontology (GO)
enrichment analysis in the “Biological Process” category for DE-genes upregulated or downregulated in transition versus RLM in wild-type mice (D). Venn diagram
representing DE-genes upregulated in transition macrophages versus Kupffer cells (KC APAP-D3) in wild-type and Trem-2 KO mice (E). Gene Ontology (GO)
enrichment analysis in the “Biological Process” category for DE-genes exclusively upregulated in transition macrophages of Trem-2 KO mice (F). GO terms over-
represented for FDR (Bejamini)<0.05.February 2021 | Volume 11 | Article 616044
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Endothelial Lineage Transcriptomic Profile
We next sought to discern the transcriptional program of the
non-hematopoietic CD45neg SSChi cells that accumulate in the
liver in response to tissue injury and correlate with reducedFrontiers in Immunology | www.frontiersin.org 10liver KCs and persistent liver damage (Figures 2D, E and
Figures 3G, H). The transcriptomic profiles of sorted CD45neg
SSChi cells in APAP-treated (D3) and untreated mice
(Supplementary Figure 4B) were closely related when using







FIGURE 6 | LDECs identified among the CD45neg SSChi population by transcriptomic and phenotypic analysis and their interaction with transition macrophages.
Venn diagram representing differentially expressed genes (DE-genes) upregulated in CD45neg SSChi population from APAP-D3 and untreated control mice. Kupffer
cells (KC APAP-D3) transcriptomic data was used as a reference for DE-genes comparison (A). Gene Ontology (GO) enrichment analysis in the ‘Biological Process’
category for common DE upregulated genes in APAP-D3 and control compared to KCs (B) for DE upregulated genes exclusively in APAP-D3 (C) and genes
upregulated exclusively control mice (D). GO terms over-represented for FDR (Bejamini)<0.05. Dot plot of ligand-receptor interactions between transition
macrophages (y axis) and LDECs populations (x axis). Circle color denotes average strength of the regulatory potential between sender and receiver cells. LDECs
associated gene ontology terms are identified (E). Flow cytometry plots showing double staining for CD31 and CD26 in control and APAP-D3 (LDECs) CD45neg
SSChi cells (F). Sort-purified LDECs cultured in M-CSF supplemented medium at 1, 8 and 21 days (G).February 2021 | Volume 11 | Article 616044
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genes common to control and APAP-D3 CD45neg SSChi cells
showed striking enrichment in terms related to endothelial cell
identity and function (Figure 6B). In addition, DE-genes
upregulated in CD45neg SSChi cells of APAP–D3 treated mice
revealed enrichment in pathways related to epithelial to
mesenchymal transition and to regulation of Wnt signaling
pathway (Figure 6C). On the other hand, DE-genes up-
regulated in CD45neg SSChi cells from control mice revealed
enrichment in functional pathways involved in blood
coagulation, hemostasis and fibrinolysis , typical of
endothelial cells (Figure 6D). These transcriptomic data
clearly identified the CD45neg SSChi population accumulating
in the damaged liver as belonging to the endothelial cell lineage
leading us to operationally name these cells as Liver Damage-
associated Endothelial Cells (LDECs). In addition, the
ontology analysis suggests that LDECs are undergoing
endothelial de-differentiation.
We used in silico analysis to infer interactions between
transition macrophages and LDECs during liver tissue repair.
Niche Net (30), an algorithm that predicts ligand-receptor
interactions by combining transcriptome data of interacting
cells revealed that TNF-a, ADAM17, Copa, Ebi3 and Il1b were
the top 5 transition macrophages ligands connected with LDECs
transcriptional profile, irrespective of the mice genotype (Figure
6E), This supports that a sustained pro-inflammatory profile
during macrophage phenotypic transitions, as observed in Trem-
2 KO mice, promotes LDECs accumulation.
LDECs Proliferate and Differentiate In Vitro
We characterized LDECs by flow cytometry using liver endothelial
cell surface makers, namely CD31 and CD26. Strikingly, LDECs
express lower levels of these markers as compared to endothelial
cells from control mice (Figure 6F). This is line with previous
reports showing that endothelial cells undergoing endothelial to
mesenchymal transition downregulate endothelial specific
markers such as CD31 (31). We next explored the ability of
sort-purified LDECs to differentiate in vitro in presence of
macrophage-colony stimulating factor (M-CSF), a growth factor
able to promote angiogenesis (32). LEDCs were very small and
granulous until day 8 when larger sized, round-shaped cells
emerged and expanded in the culture, eventually developing
typical endothelial morphology by 21 days (Figure 6G). These
results reveal that LDECs are at a particular activation state
characterized by down-modulation of endothelial cell markers
and ability to differentiate into morphologically distinct cells,
indicative of their precursor potential.DISCUSSION
This work revealed that Trem-2 controls the replenishment of
liver macrophage populations after acute and chronic
hepatotoxic damage and is a critical determinant of swift tissue
repair responses conditioning the emergence of endothelial
lineage cells during regeneration. Recent reports proposedFrontiers in Immunology | www.frontiersin.org 11that lack of Trem-2 expression in non-parenchymal cells
contributes to increased fibrosis in Trem-2 KO mice submitted
to CCl4 treatment, to increased liver inflammation after acute
APAP treatment (24) and to increased susceptibility to
hepatocarcinogenesis (33). We noted that Trem-2 KO mice did
not show significantly higher intensity of liver damage during
acute injury (APAP-D1) but showed sustained tissue damage
throughout the tissue repair phase (APAP-D3). Likewise, Trem-
2 KO mice presented slightly heightened necrosis during the
inflammatory phase of chronic liver injury (CCl4-D1) and a
marked delay in subsequent resolution of tissue necrosis and
fibrosis (CCl4-D3). While Trem-2 may influence the initial
hepatic inflammatory and fibrotic reactions (24), here we
focused on its impact in liver macrophages responses during
recovery from drug-induced damage.
Macrophage phenotypic plasticity is well illustrated in the
responses to liver tissue damage (8, 9). In particular, we identified
a transition macrophage population that expresses Trem-2 in
high levels and predominates during the recovery phase from
acute and chronic damage. These cells are derived from
circulating monocytes and both transcriptional and phenotypic
profiling placed them as the immediate source of resident-like
macrophages (Kupffer cells) in the recovered liver. These
observations strongly suggest that Trem-2 signaling plays a key
role in the dynamics and efficiency of this phenotypic transition,
thus explaining the delayed replenishment of the KCs
compartment in Trem-2 KO mice. Noteworthy, recent reports
have shown that replenishment of the Kupffer cell niche occurs
upon engraftment of circulating monocytes into the
perisinusoidal space, which is dependent of coordinate
interactions between hepatocytes, stellate cells and endothelial
cells in the liver (34). These interactions induce a particular
transcriptional program and epigenetic changes, responsible for
the induction and maintenance of Kupffer cell identity (35). Also,
a scar-associated Trem2+CD9+ subpopulation of macrophages
was identified in cirrhotic human livers (36). Interestingly, a
recent report has shown that in a mouse model of NASH,
Kupffer cells are lost mostly likely by apoptosis which induced
Trem-2 expression and replenishment of the KC compartment
by monocyte-derived macrophages (37).
In addition, a Trem-2 dependent transcriptional program has
been associated with emergence of restorative macrophage
populations in the context of brain tissue degeneration and
adipose tissue inflammation (21, 22). Similarly, liver transition
macrophages show upregulation of genes associated with this
Trem-2 dependent transcriptional signature (Supplementary
Figure 7).
Taken together, our results contribute to the identification of
Trem-2 as a critical determinant of macrophage plasticity
instrumental for a swift recovery from tissue damage.
Acquisition of the transition phenotype in wild-type
macrophages includes down-modulation of pro-inflammatory
genes and up-regulation of genes involved in oxidative stress
responses, not observed in Trem-2 KO macrophages. Redox
regulation is critical to cellular stress control mechanisms (38).
Accordingly, transition macrophages from Trem-2 KO miceFebruary 2021 | Volume 11 | Article 616044
Coelho et al. Trem-2 in Liver Repair Responsesshowed decreased survival and proliferative capacities. These
observations are in line with reports of reduced survival of
Trem-2 KO microglia cells during neurodegenerative processes
(17, 39). Furthermore, reactive oxygen species (ROS) were
increased in Trem-2 KO bone-marrow derived macrophages
and hepatic lipid peroxides were increased during liver damage
in Trem-2 KO mice (24). Together, these findings indicate
that transition macrophages may play a relevant role in
ROS clearance in damaged liver and that Trem-2 expression
is likely fundamental for transition macrophage survival
and proliferation, therefore allowing their acquisition of
KCs phenotype.
Remarkably, ablation of Trem-2 leads to increased
accumulation of a non-hematopoietic population that we
identified as Liver Damage Endothelial Cells (LDECs). This
population appeared during tissue repair phases and its
accumulation correlated with the severity of tissue damage. It
has been recently proposed that vascular endothelial stem cells
residing in the liver are activated upon acute liver injury and act
as angiogenesis-initiating cells showing remarkable vascular
regenerative capacity (40). On the other hand, a specific
subset of liver sinusoidal endothelial cells was found to
sustain liver regeneration after hepatectomy by releasing
angiocrine trophogens (41). Nevertheless, the development
and rules of engagement of endothelial progenitors in liver
angiogenic repair responses remain unclear.
LDECs transcriptional profile denotes a differential functional
activation status as compared to endothelial cells from untreated
livers. Gene ontology analysis revealed that LDECs are involved
in biological processes related to epithelial to mesenchymal
transition (Figure 6C). A similar process designated
endothelial to mesenchymal transition (EndMT) has been
reported to play important roles in pathogenesis of many
diseases (42) as well as in regenerative processes (31). EndMT
promotes cell de-differentiation, consequently giving rise to
mesenchymal stem cells with the ability to differentiate into
new cell types (43). These cells were shown to differentiate into
endothelial cells that contribute to neovascularization (42).
Interestingly, M-CSF, an essential regulator of macrophage
development, induced marked LDECs morphological changes
in vitro, highlighting their de-differentiated state and intrinsic
proliferative and differentiation potential.
In silico analysis of predicted ligand-receptor suggests an
interaction between transition macrophages and LDECs, where
inflammatory mediators secreted by macrophages activate a
transcriptional profile on endothelial cells. Of note, ligands such
as TNF-a and Il1b showed established correlation with
transcription of Sox9, Selp and Ccr7, which are expressed by
LDECs. It is well accepted that TNF-a and Il1b are able to activate
endothelial cells and promote angiogenesis (44, 45) as well as
potentiate leukocyte transmigration into inflamed tissues (46).
Noteworthy, a recent report used in silico analysis to highlight liver
macrophage-endothelial cell interactions in the context of
cirrhosis. The authors describe a particular scar associated
macrophage subpopulation expressing Trem2 as well as
endothelial populations restricted to the fibrotic niche (36).Frontiers in Immunology | www.frontiersin.org 12These observations corroborate our findings that, in damaged
liver, macrophages and endothelial cell populations are interlinked
and may represent a hallmark of liver regenerative responses.
Nevertheless, the precise mechanism mediating this interaction
warrants further investigation.
In sum, this work describes Trem-2 as a promotor of
macrophage phenotypic switching during tissue repair, tuning
down the recruited macrophage inflammatory profile,
enhancing oxidation-reduction responses and allowing KCs
replenishment. In parallel, we identified an endothelial cell
population (LDECs) that emerges during tissue repair with a
distinct transcriptional profile and phenotypic features of
endothelial de-differentiation.DATA AVAILABILITY STATEMENT
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Supplementary Figure 1 | Transition macrophages and Kupffer cells show
different expression of Tim4 and Clec4f. Flow cytometry analysis of liver non-
parenchymal cells (NPCs) from wild-type and Trem-2 KOmice, untreated and at D3
post APAP injury. Macrophage populations were identified within CD45+ cells.
Resident macrophage makers, Tim4 and Clec4f, were used to identify Kupffer cells.
Transition macrophages and Kupffer cells were identified using CD11b and F4/80
within Tim4+Clec4f+ gate and within Tim4-Clec4f- gate.
Supplementary Figure 2 | Serum CD26 activity during recovery from acute liver
damage and fibrosis regression. CD26 activity represented in arbitrary units (A.U.)
was measured in the serum of wild-type and Trem-2 KOmice, during recovery from
APAP (D3) (A) and during fibrosis regression (D3) induced by CCl4 (B) or in mice left
untreated (Ctrl). Symbols represent individual mice. One-way ANOVA *, p<0.05 ***,
p<0.001.
Supplementary Figure 3 | Recruited monocyte tracking in liver macrophage
populations following acute liver damage. Monocytes from B6.Actin-GFP mice
were intravenously injected 12 hours after APAP treatment in wild-type mice and
non-parenchymal cells were isolated at APAP-D3. Flow cytometry histogramsFrontiers in Immunology | www.frontiersin.org 13show enrichment in GFP+ cells compared to non-transferred mice in different
macrophage populations: RLM, Transition and Kupffer cells.
Supplementary Figure 4 | Accumulation of CD45neg SSChi cells correlates with
expression of pro-inflammatory cytokines in the liver. Positive correlation between
frequency of CD45neg SSChi population and TNFa gene expression in liver non-
parenchymal cells during recovery from chronic injury (CCl4-D3). Statistics:
Pearson’s correlation test.
Supplementary Figure 5 | FACsort-purified macrophage populations and
CD45neg SSChi cells for transcriptomic analysis. Wild-type and Trem-2 KO mice
received a single intraperitoneal injection of APAP and macrophage populations and
CD45neg SSChi cells were sorted at APAP-D3 and in control mice. Macrophage
populations were identified using CD45, Ly6c, CD11b and F4/80markers and the purity
of each population after sorting is shown (A). CD45neg SSChi population was identified
using CD45marker in APAP-D3 and in control mice and the purity after sorting is shown
(B). Each sample for transcriptomic analysis was obtained from pools of 4 mice.
Supplementary Figure 6 | Heatmaps of DE-genes representing hierarchical
clustering of macrophage and CD45neg SSChi cell populations. Heatmap
represents 100 KCs associated genes42 for different macrophage populations (A).
Heatmap showing differentially expressed (DE) genes in CD45neg SSChi cells using
KCs as reference: 821 genes upregulated in APAP-D3, 117 upregulated in control
and 428 common to APAP-D3 and control as identified in Figure 2.6A (B).
Supplementary Figure 7 | Gene expression and transcriptomic analysis of
macrophage populations. Hmox1 and Fth1 gene expression was evaluated by
qPCR in sort-purified KCs, transition and RLM populations from wild-type and
Trem-2 KO mice at APAP-D3 (A). Volcano plots representing differential expressed
(DE) genes (q<0.05) between RLM and RHM in wild-type and Trem-2 KOmice. Red
dots represent upregulated genes with LogFC>0, while blue dots represent
downregulated genes with LogFC<0 significant for q<0.05 (B). Venn diagram
representing DE-genes between RLM and RHM which are common to wild-type
and Trem-2 KO (middle), exclusive for wild-type (left) or Trem-2 KO (right). Gene
Ontology (GO) enrichment analysis in the ‘Biological Process’ category for DE-
genes in wild-type mice and Trem-2 KO mice (C). Heatmap illustrating genes
regulated by Trem-2 in transition macrophages. Log fold change (logFC) of genes
previously associated to Trem-2 transcriptional signature (21, 22). Heatmap
represents DE-genes upregulated in transition versus RLM at APAP-D3 in wild-type
and Trem-2 KO miceREFERENCES
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